CH Biotech R&D Co., Ltd. (6534.TW) has a MoatMap StockRank of 84/100 based on Quality (79/100), Value (50/100), and Momentum (39/100) factor scores. The current signal is STRONG BUY. CH Biotech R&D is an asset-light agricultural biotechnology leader with an exceptional quality profile (Q: 79). As the commodity supercycle drives up fertilizer and agricultural input costs, farmers are forced to seek yield-maximizing efficiency. CH Biotech's proprietary plant growth regulators and bio-stimulants offer a high-ROI solution, giving the company immense pricing power and a long reinvestment runway.
CH Biotech R&D Co., Ltd. researches, develops, and manufactures plant growth regulators, biostimulants, and specialty fertilizers. The company maintains a strong competitive advantage through proprietary agricultural biotechnology and a strategic distribution partnership with Nutrien. It is a leading, research-driven agricultural biotechnology company focused on sustainable crop yield enhancement.
| Price | $2.83 |
| Market Cap | $314M |
| P/E (TTM) | 20.16 |
| Price/Book | 3.48 |
| Return on Equity | 18.3% |
| Return on Invested Capital | 20.5% |
| Debt/Equity | 23.44 |
| Gross Margin | 83.7% |
| Operating Margin | 59.6% |
| Revenue Growth | 1.9% |
| Dividend Yield | 5.3% |
| Free Cash Flow | $558K |
CH Biotech R&D Co., Ltd. operates in the Agricultural Inputs industry, part of the Basic Materials sector (Taiwan).